Trial Outcomes & Findings for Role of Bone in Knee Osteoarthritis (OA) (NCT NCT00850538)

NCT ID: NCT00850538

Last Updated: 2015-12-04

Results Overview

Recruitment status

COMPLETED

Target enrollment

101 participants

Primary outcome timeframe

Tissue samples collected at time of surgery

Results posted on

2015-12-04

Participant Flow

Participants were recruited from 4 orthopedic surgeons at one hospital between the dates of March, 2009 and April, 2013.

Participant milestones

Participant milestones
Measure
Enrolled
Inclusion Criteria: \- subjects having primary knee replacement surgery Exclusion Criteria: * having a revision knee replacement instead of a primary knee replacement * contraindicated for MRI or CT scans * allergy to the contrast agent gadolinium * pregnant women
Overall Study
STARTED
101
Overall Study
COMPLETED
60
Overall Study
NOT COMPLETED
41

Reasons for withdrawal

Reasons for withdrawal
Measure
Enrolled
Inclusion Criteria: \- subjects having primary knee replacement surgery Exclusion Criteria: * having a revision knee replacement instead of a primary knee replacement * contraindicated for MRI or CT scans * allergy to the contrast agent gadolinium * pregnant women
Overall Study
unable/unwilling to complete MRI
13
Overall Study
specimen missed due to scheduling error
14
Overall Study
specimen unusable
7
Overall Study
Withdrawal by Subject
3
Overall Study
radiology error
2
Overall Study
Protocol Violation
2

Baseline Characteristics

Role of Bone in Knee Osteoarthritis (OA)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Enrolled
n=101 Participants
Subjects having primary knee replacement surgery Exclusion Criteria: * having a revision knee replacement instead of a primary knee replacement * contraindicated for MRI or CT scans * allergy to the contrast agent gadolinium * pregnant women
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
55 Participants
n=5 Participants
Age, Categorical
>=65 years
46 Participants
n=5 Participants
Age, Continuous
63.89 years
STANDARD_DEVIATION 8.59 • n=5 Participants
Sex: Female, Male
Female
50 Participants
n=5 Participants
Sex: Female, Male
Male
51 Participants
n=5 Participants
Region of Enrollment
United States
101 participants
n=5 Participants

PRIMARY outcome

Timeframe: Tissue samples collected at time of surgery

Outcome measures

Outcome measures
Measure
Specimens
n=60 Participants
Viable specimens for genetic analysis
Number of Participants With Viable Specimens for Genetic Analysis
14 participants

Adverse Events

Enrolled

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Carl Talmo

New England Baptist Hospital

Phone: 617-724-5474

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place